+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 4 Actively Recruiting clinical trials

P

Actively Recruiting

This research aims to collect clinical data on the safety and performance of a range of TEKNIMED bone substitute products, including CERAFORM, TRIHA, NANOGEL, and their private labels. These synthetic bone substitutes have been used for over 20 years and are designed to fill bone voids in various surgical or traumatic bone defects. The study is a global, single-arm, non-controlled, multicenter observational study that follows patients according to the local standard medical care at each site. Participants will receive bone substitutes during surgeries such as bone grafting, spinal fusion, and cage filling. These products are bioresorbable and gradually replaced by natural bone during healing. The study includes both retrospective and prospective data collection, with the retrospective group having undergone surgery since January 1, 2015, and the prospective group being considered for surgery using these bone substitutes. The aim is to assess real-life safety and performance in current clinical practice. During the study, participants will be monitored through standard medical care visits up to 24 months to evaluate successful bone repair. Researchers will assess outcomes including pain relief, bone reconstruction, patient well-being, and satisfaction. Data collection involves clinical follow-ups and observations without additional procedures beyond routine care. The study extends until September 2032, ensuring long-term safety and effectiveness data in real-world settings.

Age: 18Years +All Genders
6 locations
R

Actively Recruiting

Researchers are evaluating the Omnipod 5 Automated Insulin Delivery System in people with type 1 diabetes aged 2 years and older. This study aims to observe real-world use of the device over 12 months, focusing on blood sugar control, quality of life, patient satisfaction, and rates of acute diabetes complications. The study is non-interventional and prospective, involving multiple centers in France. Participants use the Omnipod 5 System, a tubeless automated insulin pump designed to deliver insulin under the skin and used with compatible continuous glucose monitors such as the FreeStyle Libre 2 Plus sensor. The study follows patients for 12 months after they start using the system in automated mode. During this time, researchers collect data on how well blood sugar levels are controlled and how participants use the device. Throughout the study, participants complete quality-of-life questionnaires and treatment satisfaction surveys at the start, 6 months, and 12 months. Data on glucose levels, insulin delivery, and diabetes complications are collected continuously during the 12-month period. Safety, device usage patterns, and reasons for stopping the system are also monitored. Participants remain under their usual medical care while contributing data to this observational study.

Age: 2Years +All Genders
24 locations
S

Actively Recruiting

This research aims to collect real-life clinical data on the safety and performance of TEKNIMEDs range of spine bone cements, including SPINEFIX, HIGH V, OPACITY, and F20, along with their mixing and injection systems. These bone cements have been used for over 10 years, and their safety and effectiveness have been supported by previous studies. The study focuses on vertebroplasty, kyphoplasty, and pedicle screw augmentation procedures, which are used to treat painful vertebral compression fractures and improve mechanical stability, especially in osteoporotic patients. The study observes patients treated with TEKNIMED spine bone cements during vertebroplasty and kyphoplasty procedures, where cement is injected into fractured vertebrae to relieve pain and stabilize the bone. It also includes pedicular screw augmentation, where cement is injected to strengthen screw fixation. The study is non-controlled, multicentric, and combines both retrospective and prospective data collection, following patients according to local standard medical care. Participants will be monitored over time with assessments focusing on pain relief, quality of life, patient satisfaction, vertebral stabilization, and pain medication use for up to 24 months. Safety is tracked through adverse event collection over 10 years. Data are gathered from clinical records without altering usual care. This approach will provide long-term insights into the real-world use of TEKNIMED spine bone cements in spine surgery.

Age: 18Years +All Genders
12 locations
R

Actively Recruiting

Researchers are evaluating the ongoing safety, glycemic control, quality of life, and usage rate of the Control-IQ System in people with type 1 diabetes in France. This post-market surveillance study aims to monitor severe metabolic complications such as severe hypoglycemia and diabetic ketoacidosis over 12 months of real-world use. It is a single-arm, prospective cohort study that includes all approved populations using the system. Participants will use the tslim X2 insulin pump with Control-IQ technology combined with a Dexcom G6 or G7 continuous glucose monitoring sensor. They will follow standard care and continue use of the system for at least 12 consecutive months after enrollment. The study gathers data on device performance, patient satisfaction, usability, and quality of life throughout this period. During the study, participants will provide clinical data including HbA1c results from up to 4 months prior and during the study period. They will complete questionnaires about treatment satisfaction, system usability, quality of life, and fear of hypoglycemia. Researchers will measure rates of diabetic ketoacidosis and severe hypoglycemia, time spent in target glucose ranges, and system usage. The total participation duration is 12 months, with safety and device use closely monitored.

Age: 6Years +All Genders
25 locations